Pharmacokinetic Differences Between Cobicistat and Ritonavir on Warfarin

被引：1
|
作者：
Fulco, Patricia Pecora [1 ]
Bannister, Laura Hill [1 ]
机构：
[1] Virginia Commonwealth Univ Hlth, Richmond, VA 23219 USA
来源：
ANNALS OF PHARMACOTHERAPY | 2018年 / 52卷 / 11期
关键词：
D O I：
10.1177/1060028018784038
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1165 / 1166
页数：2
相关论文
共 50 条
  • [21] Pharmacokinetic Interaction Between Prasugrel and Ritonavir in Healthy Volunteers
    Ancrenaz, Virginie
    Deglon, Julien
    Samer, Caroline
    Staub, Christian
    Dayer, Pierre
    Daali, Youssef
    Desmeules, Jules
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 112 (02) : 132 - 137
  • [22] The pharmacokinetic interaction between ivacaftor and ritonavir in healthy volunteers
    Liddy, Anne Marie
    McLaughlin, Gavin
    Schmitz, Susanne
    D'Arcy, Deirdre M.
    Barry, Michael G.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (10) : 2235 - 2241
  • [23] Beneficial pharmacokinetic interaction between atazanavir and lopinavir/ritonavir
    Pham, Paul A.
    Flexner, Charles
    Parsons, Teresa
    Vasist, Lakshmi
    Fuchs, Edward
    Carson, Kathryn
    Agarwala, Sangeeta
    Barditch-Crovo, Patricia
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (02) : 201 - 205
  • [24] Assessment of the pharmacokinetic interaction between ritonavir(R) and clarithromycin
    Ouellet, D
    Hsu, A
    Granneman, GR
    Carlson, G
    Guenther, H
    Mukherjee, D
    Locke, C
    Leonard, JM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PI58 - PI58
  • [25] Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers
    Khaliq, Y
    Gallicano, K
    Tisdale, C
    Carignan, G
    Cooper, C
    McCarthy, A
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (06) : 591 - 600
  • [26] Cobicistat versus ritonavir boosting and differences in the drug-drug interaction profiles with co-medications
    Marzolini, Catia
    Gibbons, Sara
    Khoo, Saye
    Back, David
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (07) : 1755 - 1758
  • [27] Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteers
    Hsu, A
    Granneman, GR
    Cao, GL
    Carothers, L
    Japour, A
    El-Shourbagy, T
    Dennis, S
    Berg, J
    Erdman, K
    Leonard, JM
    Sun, EG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 2784 - 2791
  • [28] NO PHARMACOKINETIC OR PHARMACODYNAMIC INTERACTION BETWEEN RIVASTATIN AND WARFARIN
    SCHALL, R
    MULLER, FO
    HUNDT, HKL
    RITTER, W
    DUURSEMA, L
    GROENEWOUD, G
    MIDDLE, MV
    JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (03): : 306 - 313
  • [29] Lack of pharmacokinetic interactions between argatroban and warfarin
    Brown, PM
    Hursting, MJ
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (21) : 2078 - 2083
  • [30] Increase in international normalized ratio after switching from atazanavir/ritonavir to darunavir/cobicistat in a patient on warfarin: boosters are not always equal
    Tseng, Alice L.
    Luetkehoelter, Jonathan
    Walmsley, Sharon L.
    AIDS, 2017, 31 (01) : 175 - 176
12345